Plexus Corp: Form 10-Q for the period ended Mar 30, 2024
Filed with the SEC on May 3, 2024 and accepted by EDGAR at May 3, 2024, 12:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-12-31 to 2024-03-30 | $997.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-10-01 to 2024-03-30 | $2.01bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-12-31 to 2024-03-30 | $878.8m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-10-01 to 2024-03-30 | $1.77bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2023-12-31 to 2024-03-30 | $88.1m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-10-01 to 2024-03-30 | $176.2m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2023-12-31 to 2024-03-30 | $47.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-10-01 to 2024-03-30 | $90.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-12-31 to 2024-03-30 | $29.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-10-01 to 2024-03-30 | $74.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-12-31 to 2024-03-30 | $8.3m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-10-01 to 2024-03-30 | $15.9m | us-gaap:InterestExpense |
| Income tax | 3 months2023-12-31 to 2024-03-30 | $2.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-10-01 to 2024-03-30 | $8.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-12-31 to 2024-03-30 | $16.2m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-10-01 to 2024-03-30 | $45.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-12-31 to 2024-03-30 | $0.58 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-10-01 to 2024-03-30 | $1.62 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-12-31 to 2024-03-30 | $0.59 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-10-01 to 2024-03-30 | $1.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-12-31 to 2024-03-30 | 27,929,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-10-01 to 2024-03-30 | 27,982,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-10-01 to 2024-03-30 | $84.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-10-01 to 2024-03-30 | $51.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2023-10-01 to 2024-03-30 | $17.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-30 | $265.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-30 | $2.63bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-30 | $3.28bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-30 | $1.74bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-30 | $2.02bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-30 | $1.26bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000785786-24-000033. Last ingested by Listed: Oct 24, 2026, 14:56 ET. Listed shows no prices and gives no investment advice.